Introduction: Generalized anxiety disorder (GAD) is a common clinical condition reported at psychiatric hospitals. Reasonable estimates for its one year prevalence range from 3 to 8%. It is characterized by excessive, uncontrollable and irrational worries about day to day events. Most of the features of GAD are similar with that of chittodwega in Ayurveda.
INTRODUCTION
Anxiety disorders are among the most prevalent psychiatric condition in the world. Estimates indicate one year prevalence range from 3 to 8%, 1 and lifetime prevalence between 5 to 8%. 2 The disorder usually has its onset in late adolescence or early adulthood. Occasionally cases are also seen in the older age. GAD is characterized by persistent excessive anxiety and worries about day to day events or activities at least for a period of 6 months. 3 The worry may be difficult to control and associated with various somatic symptoms. Patients (50-90%) suffering from GAD will have coexistence of other mental disorder like social phobia, panic disorder or depressive disorder. About 25% of patients associated with panic disorder. 4 Genetic, biochemical, environmental and psychological profiles form major risk factors for GAD. People having personality traits like anxiety, anger, hostility, impulsiveness, pessimism, and depression are more prone to GAD. Many patients with anxiety disorders report overprotective and unaffectionate parents. Stressful events, disagreements with parents and close relatives, posttraumatic stress syndrome, specific traumatic events in childhood may cause anxiety disorders.
Chronic anxiety disorder may also increase the risk of other non-communicable disease (NCD) related morbidity. Hence, clinicians in psychiatry and other specialties need to make proper diagnosis of anxiety disorder and initiate treatment at the earliest. 3 As per DSM-IV diagnostic criteria for GAD suffering with excessive anxiety and worry in a day to day events persisting at least for 6 months along with the presence of at least four out of the following six symptoms, i.e., restlessness, fatigue, difficulty in concentrating, irritabil-ity, muscle tension and Sleep disturbances. The treatment options available in contemporary medicine are pharmacotherapy and psychotherapy in the form of cognitive behavioral therapy and counselling. In Ayurveda features chittodwega is similar with that of GAD.
Chittodwega is one among many types of Manasika Vikara explained in Ayurveda. 'Anavasthita Chitta' is explained under 80 types of Nanatmaja Vata Vikara. Indriyas and manas get vitiated due to excessive, deficient and improper indulgence and disorders of corresponding sensory perceptions manifest. 4 Chintana is the object of mind and when impairment in cognition and decision making occur it results in the manifestation of various types of psychological disorders. Due to Astmendriyartha samyoga, Prajnaparadha and Parinama shareeraka and Manasika doshas get vitiated.
Sthana samshraya of Manasika doshas occurs in hridaya.
As hridaya is the sthana of manas it also gets vitiated resulting in manovaha srotodusti and production of manasika lakshana of chittodwega. Vitiated Vatadi doshas impair Agni which inturn vitiate rasadi dhatus. This results in the manifestation of various somatic manifestations observed in Chittodwega. 5 Herbs like Brahmi (Bacopa monnieri), Mandukaparni (Centella asiatica), Sankhapushpi (Convolvulus pluri caulis), Guduchi (Tinospora cardifolia), Ashwagandha (Withania somnifera) are indicated for treating manovikara. Among these Ashwagandha is said to be rasayana and yogavahi. 6 Mandookaparni is a Medhya Rasayana having effect in reducing tension and stress. 7 Shirodhara is a treatment procedure included under 'moordhataila' having beneficiary effect in all types of psychiatric disorders. 8 Prior studies conducted with Ashwagandha and Mandookaparni individually have shown beneficiary effects in GAD patients in small samples. But this study proposes the combined effect in GAD patients with or without Shirodhara in a significantly large sample.
Justification for Selecting Trial Drugs and Treatment Procedure
Ashvagandha: It is explained as a rasayana drug which reduces stress, tiredness and promote immune responses. It is explained as anti-stress and adaptogenic drug. Its efficacy is not tested in a randomized control trial earlier in GAD. In a controlled study conducted among stressed adults, the group that was supplemented with Ashvagandha had more significant reduction in 'Cortisol' than in the control group. Cortosol is a stress hormone which is released by adrenal glands in response to stress and when blood sugar levels become low.
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Ashvagandha also promotes antioxidant activity and reduces oxidative stress.
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Mandukaparni: Acts like a tonic and a mood elevator in conditions like stress, anxiety, tension, depression, etc., it is used as a sedative. The effect is mainly due to the 'brahmoside' and 'brahminoside' constituents. Anxiolytic activity is considered to be due to binding to 'cholecystokinin' receptors (CCKB) a group of G protein composed receptors which bind the peptide hormone cholecystinokinin (CCK) or gastrin and were thought to play a potential role in the modulation of anxiety.
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Shirodhara: Shirodhara is a classical and a well-established Ayurvedic procedure. This procedure induces a relaxed state of awareness that results in a dynamic psychosomatic balance. 12 Shirodhara is one of the most powerful treatments to relieve Vata (wind) in the mind preoccupied with swarming thoughts, which can lead to inability to handle stress, creating nervousness, anxiety, depression, insomnia, fatigue, psychological disorders. Scope of work and contribution to the field: Work aims at clinical safety and outcome of Ayurveda formulations and treatment in GAD patients is undertaken.
MATERIALS AND METHODS
The 
Source of Data
A total of 100 participants were enrolled in the clinical trial from the OPD unit of the hospital. Patients were screened in accordance with the inclusion and exclusion criteria mentioned in the protocol and were recruited for the study after obtaining the written informed consent. The enrolled patients were randomly assigned in to two groups of 50 patients each.
Inclusion Criteria
Patients of either sex aged between 18 to 45 years who were diagnosed based on DSM IV diagnostic criteria for GAD, were included in the trial.
Exclusion Criteria
Patients suffering from any other systemic disorders, patients in whom GAD is associated with any other psychiatric illness like depression, social phobias, psychotic disorders, etc. Any abnormalities in values of thyroid profile and electrocardiogram (ECG) were also excluded.
Study Interventions
Trial patients were randomly divided into two groups and the following intervention were done. Group I: Patients of this group were orally administered with Ashwagandha churna in the dose of 1.5 gm (3 tablets of 500 mg) twice daily and Mandookaparni churna tablets in the dose of 1.5 gm (three tablets of 500 mg) twice daily with water for 12 weeks after intake of food.
Group II: Patients were administered with similar oral medications as in patients of Group I. In addition they were also subjected to Shirodhara with Ksheerabala taila for 30 minutes daily for an initial seven days only. All the medicines used in the trial were procured from good manufacturing practice certified Ayurvedic pharmaceutical industries and standardized following the standards as per ayurveidc pharmacopeia of India. 
Timelines (Flow Chart 1)

Outcome Measure
Assessment of changes in total and individual constituents of Hamilton anxiety rating scale was adopted for assessment. Ayurvedic factors assessed include Dashavidha and Sroto Pariksha. At the study site data of all the patients were recorded in pre-designed case report forms (CRFs) and was also entered in electronic formats (e-formats) designed in ms-excel with many data validation checks to ensure correct data entry. The e-formats and xerox of the CRFs along with the laboratory investigations reports of the patients were sent by the participating center to the council's headquarters on weekly basis for the purpose of clinical trial monitoring.
Out of the total 100 patients, enrolled in the study, 14 were dropped out during the course of the study. Intention-to-treat analysis was done and the data of all those patients who have completed at least 84th day visit were imputed by last observation carried forward (LOCF) method. Hence, data of a total 100 patients was used for statistical analysis.
Statistical Analysis
The outcome measures that are the components of HRS values were analyzed as mean change in the response from baseline to 84th day by using paired t-test. A p-value of < 0.05 was considered significant. Analysis was carried out using statistical package for social 
RESULTS
Data of a total 100 patients was used for statistical analysis. Majority of the patients were males, i.e., 71%. A demographic profile of the patients showed that 3% of the patients were illiterate and 97% knew how to read and write. Sixty-five percent of the patients used to do desk work, 20% of the patients do field work with physical labor, and 15% of the patients were housewives. It was also observed that the maximum number of patients (78%) were of Vata pittaja prakriti. Table 1 shows the basic information and demographic profile of the patients (Flow Chart 2).
Details obtained during history taking showed a majority of patients reports personality traits like anger, hostility, impulsiveness, and pessimism. Among the family-raleated factors, family disputes and stressful environment at home were reported in majority of patients. Failure in academics and financial distress also reported in the majority of cases.
Among the systemic examination findings gastroaintestinal tract related and musculoskeletal symptoms were predominant. Vata pittaja prakriti was found in 79% of patients (Tables 2 and 3) .
Chief complaints faced by the patients suffering from GAD were assessed by hamilton rating scale. Efficacy of the treatments in both groups on individual components of HRS was calculated by using 'wilcoxon signed ranks test (Tables 4 to 7) .
Response of Patients Towards the Treatment at Baseline and 84th day in both groups
The response of the patients towards individual components of the Hamilton rating scale is tabulated in the following Table 7 . In all the components the number of patients in severe status has been changed to mild or moderate or none status.
Effect of the Drugs on Safety Parameters
The effect of this treatment on liver function tests (LFT) and renal function tests (RFT) was assessed at baseline and at 84th day. The values are within normal range before and after trial period (Table 8 ). These observations validate that the trial medicines are safe for human use. Further, no adverse drug effect or adverse events were reported during the treatment period.
DISCUSSION
In the manifestation of Manodwega, both Vata and Manas are involved. Vata and Manas are interdependent and gets vitiated together. The predominant doshas of the Manas are Raja and Tama. 13 The nidanas which vitiate
Vata, Raja and Tamas are considered as etiological factors of Manodvega. Any intervention selected for the management should aim to control these three factors. Acharya charaka explained three types of therapies for the management of physical and mental disorders, i.e., Daiva vyapashraya (spiritual therapy), Yukti vyapashraya (pharmacotherapy) and Satvavajaya (psychotherapy).
14 Yukti vyapasraya chikitsa in the form of oral medications and shirodhara are employed in this trial. Acharya charaka also advices Medhya rasayana to promote the mental health and to treat mental disorders like Chittodvega (GAD), etc. A rasayana oushadhi imparts the body with the longevity of life, memory, intelligence, disease free status and delayed aeging. Mandukaparni is one of the best Medhya dravya. It has sedative, hypotensive and anxiolytic actions. It enhances memory and grasping power and is used as a brain tonic. It is beneficial in Alzheimer's disease, anxiety and depression. In a previously conducted randomized placebo-controlled study on 100 patients suffering from minor disturbances of cerebral higher mental functions observations showed the increased feeling of wellbeing with mental and physical fitness, attention, memory, calculation, abstract thought, visual and body perception. 16 According to scientific interpretation, Mandookaparni is likely to increase the CNS alpha wave activity and simultaneously decrease beta wave activity. Increase in alpha wave activity in the EEG is shown to be associated with a state of relaxation of the body and mind and reduces the fluctuations of mind. There by concentration ability and improvement in overall positive mental health occur. 16 Medhya rasayana drugs like Mandookaparni and Brahmi possesses similar action like that of nootropic agents Values are expressed as n (%) which enhances the oxygen supply and better glucose utilization in brain cells. The altered blood supply ensures better psychostimulation producing positive effects on cerebral higher functions like memory, intelligence and learning abilities. 16 Ashwagandha is said to have anti-stress, adaptogenic, aphrodisiac, sedative, diuretic, antispasmodic, germicidal and anti-inflammatory actions. It is a nervine tonic and enhances immunity. Due to its anxiolytic effect, it decreses stressful situation and is effective in Insomnia.
Its Tikta rasa and Ushna veerya alleviates Vata and Kapha. Ashwagandha is a rejuvenative and has has a calming effect on anxiety symptoms when compared to the drug lorazepam (a sedative and anxiety medication). A study published in the journal Phytomedicine showed that the herb had the ability to reduce anxiety levels. A clinical study conducted previously to assess the anti stress effect of Ashwagandha (Withania somnifera) established improvement in a physical feeling of well being and psychological improvement in terms of reduced anxiety level, adjustment, memory span, mental fatigue rate, sleep pattern, etc. Improvement was observed in significant reduction of anxiety level suggesting marked tranquillity state of mind. 17 In another clinical study conducted with Ashwagandha leha on 156 apparently healthy individuals for assessing rasayana effect showed highly significant result in imroving quality of life, visual analog scale (VAS) score, Hamilton depression rating scale score and PGI memory scale score.
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The neuro-physiological mechanism of the effects of Shirodhara on the psycho-physiological changes may be related to the tactile stimulation of the skin or hair follicles innervated by the first branch of the trigeminal nerves (ophthalmic nerve). The impulses would be transmitted to the thalamus through the principal nucleus and forward to the cerebral cortex (somatosensory field) or limbic system. 19 In the procedure of Shirodhara, a particular pressure and vibration is created Values are expressed as mean and standard deviations. The scores on individual symptoms of HAM-A were compared by using Wilcoxon signed rank test at baseline and 84th day, *p-value of <0.05 has been considered as significant In Group I Mean score of Hamilton rating scale was decreased from 19.38 at baseline to 15.02 at 84th day. In Group II Mean score of Hamilton rating scale was decreased from 18.62 at baseline to 14.38 at 84th day.
over the forehead. The vibration is amplified by the hollow sinus present in the frontal bone. The vibration is then transmitted inwards through the fluid medium of cerebrospinal fluid (CSF). This vibration along with little temperature may activate the functions of thalamus and the basal forebrain which then brings the amount of serotonin and catecholamine to the normal stage inducing the sleep. The procedure of Shirodhara brings the Sanjnavaha Srotas in a peaceful state of rest which helps in inducing sleep. The process of Shirodhara also produces a meditation effect which helps to overcome the complaint of insomnia. In the present clinical trial as evident from results there is a significant reduction observed in the intensity of Hamilton rating scale parameters in treated patients of both groups (Table 4) . Statistically significant reduction (p-value < 0.001) was observed in components of HRS like anxiousnessness, tension, fear, insomnia, intellectual (cognitive), somatic (muscular) and autonomic symptoms in both the treated groups. There was no significant improvement observed in a depressed mood, Somatic (sensory), cyclic vomiting syndrome (CVS) symptoms, GIT symptoms, respiratory and genitourinary symptoms.
The result of the indipendant sample 't test' conducted between the groups shows that both the treated groups show a significant reduction in values of Hamilton rating scale (Table 6 ). But the efficacy between the groups is not significant. The interpretation is that in both the groups the efficacy is almost identical.
The effect of the treatment on LFT and RFT was assessed at baseline and at 84th day. The values are within normal range before and after trial period (Table 8 ). These observations validate that the trial medicines are safe for use. Further, no adverse drug effect or adverse events were reported during the treatment period.
Combination of Ashwagandha churna and Mandukaparni churna with or without combination of shirodhara performed with ksheerabala taila was found to be effective in the management of GAD which could be ascertained by its effect on the outcome parameters. Tables 5 and 6 show the effect of these two ayurvedic formulations on the outcome measures.
CONCLUSION
Since ages, Ashwagandha and Mandookaparni have been used by Ayurvedic physicians in the treatment of Manodwega (GAD), Vishada and other neuropsychiatric disorders. Even though the drugs have been studied individually in psychiatric disorders, there has not been any systematic attempt to document the effect of this combination on specific subjective and objective outcome measures based on HARS. This trial has established that 84 days of treatment with this combination of medicines administered with or without Shirodhara helps in reducing anxiety levels in patients suffering with GAD. Results have shown efficacy in reducing anxiousnessness, tension, fear, insomnia, intellectual (cognitive), somatic (muscular) and autonomic symptoms. The medicine combination is also safe to use as there was no significant influence on safety parameters which is evident by post-treatment renal and hepatic function tests. Since GAD patients require long-term medical intervention, Ashwagandha and Mandookaparni can be effective and safe in its management.
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